Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that PKP1 is essential for skin integrity and hair growth, and its dysfunction causes the symptoms of ectodermal dysplasia/skin fragility syndrome.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Mast cells might contribute to hair loss by causing skin thickening.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Trichoblastomas in rabbits are linked to uncontrolled embryonic hair growth and have distinct histological features.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Demodex mites can cause eye problems like itching, dry eyes, and styes.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

A Holstein calf in Iran with a severe genetic skin disorder was euthanized due to incurable symptoms.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Finasteride reduces prostate size and PSA levels in young patients.